Raising the Bar for Patients With SpA: Treatment Targets and a Look to The Future
Chair: Prof. Huji Xu
Axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) are multi-faceted and complex diseases. As our understanding of the underlying drivers of these conditions evolves, so does the treatment landscape. There is therefore a need to ensure that treatment approaches are optimised, so that we can raise the bar in caring for our patients with SpA. This symposium will highlight the importance and clinical value of aiming for higher treatment targets in axSpA and PsA, and will explore the key molecular drivers of axSpA and PsA to provide a fresh look at the pathobiology of SpA.
axSpA Presentation (title TBC)
Prof Huji Xu
PsA Presentation (title TBC)
Dr Atul Deodhar
Prof. Huji Xu and Prof. Atul Deodhar